Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01146834
Title Trial of Three Stem Cell Mobilization Regimens for Multiple Myeloma
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Weill Medical College of Cornell University
Indications

multiple myeloma

Therapies

Bortezomib + Filgrastim

Bortezomib + Cyclophosphamide + Filgrastim

Bortezomib + Cyclophosphamide

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.